The genetic bases of the depression and the cardiovascular disease.

1. Ana Paulina Guerra Pérez
Medicine Student

4. The DNA contains the
genetic material of
human beings, thanks
to the investigations of
this material have been
unable to find solutions
to various diseases.

5. Depression is one of the many
diseases that have not yet been found
its genetic bases.
Million
investigations
are realized in
the world to
improve the
information of
some illnesses
and to be able
to treat them.
Genetics in depression: What’s known, what’s next
January 7, 2015
Wolters kluwer Health: Lippincott Williams and Wilkin

6. GENETICS IN DEPRESSION: WHAT’S KNOWN,
WHAT´S NEXT
The studies demonstrate
a relation between the
genes and the
environment.

7. GENETICS IN DEPRESSION: WHAT’S KNOWN,
WHAT´S NEXT
• One of the studies (GWAS)
finds no relationship
between the environment
• studies (GXE) shows us
how the effects of the mine
environment are a high risk
to produce depression.

8. GENETICS IN DEPRESSION: WHAT’S KNOWN,
WHAT´S NEXT
It is expected that the
combination of studies
someday can be clarified the
causes of diseases.

9. Observation
I think that there are many
illnesses that which its causes
are not yet, for example with
the depression since it has
been difficult to find its genetic
bases in spite of so many
studies but there is had hope
that the analysis of its genes in
a future leads to finding an
explanation.

10. Cardiovascular disease affects
thousands of people in the world.
the sedentary lifestyle,
malnutrition and other factors
make the arteries collapse
causing atherosclerosis.
Personalized therapy for cardiovascular disease
January 12, 2015
Montreal Heart Institute

11. PERSONALIZED THERAPY FOR CARDIOVASCULAR
DISEASE.
Studies of Montreal heart institute show that the dalcetrapib stimulates the
production of nitric oxide (NO), it removes the inflammation and exerts
protective cardiovascular effects.

12. .
PERSONALIZED THERAPY FOR CARDIOVASCULAR
DISEASE.
The dalcetrapib reduces a heart attack at
39% and decreases atherosclerosis.
Patients who do not have the disease
worse may suffer it is you saw a reduction
in the walls of the arteries

13. PERSONALIZED THERAPY FOR CARDIOVASCULAR
DISEASE.
These studies provide a great
hope, because it is looking for
creating custom therapies treat
the cardiovascular disease
directly.

14. Observation
In this study, we can
appreciate the research
work of some
professionals, to create
new personalized
treatment with a
medication that would
improve the
cardiovascular disease.

16. MEDICAL UTILITY
New genetic studies try to be done in order to
manage to find the causes of the depression for
a later treatment.
Genetics in depression: What’s known, what´s next.

17. MEDICAL UTILITY
Thanks to genetic studies has been a new drug for treating
cardiovascular disease.
The results of the study show that the dalcetrapib reduces
some symptoms and causes of the disease.
Personalized therapy for cardiovascular disease.

18. MEDICAL UTILITY
It is no secret that more and
more diseases that are still not
much is known why is important
to make as many of these
studies.

19. BIBLIOGRAPHY
• http://www.sciencedaily.com/releases/2015/01/150112181327.
htm
• http://www.sciencedaily.com/releases/2015/01/150107122305.
htm